Health Care & Life Sciences » Biotechnology | NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
3,477.00
1,054.00
4,381.00
11,897.00
18,230.00
12,508
Cost of Goods Sold (COGS) incl. D&A
476.00
486.00
1,261.00
2,464.00
2,784.00
1,503
Gross Income
3,001.00
568.00
3,120.00
9,433.00
15,446.00
11,005
SG&A Expense
18,487.00
17,446.00
24,134.00
20,577.00
22,757.00
18,876
EBIT
15,486.00
16,878.00
21,014.00
11,144.00
7,311.00
7,871
Unusual Expense
555.00
1,664.00
2,149.00
2,169.00
101.00
1,311
Non Operating Income/Expense
1.00
22.00
96.00
164.00
12.00
19
Pretax Income
16,040.00
15,192.00
18,961.00
13,149.00
7,400.00
6,541
Income Tax
2.00
2.00
12.00
2.00
3.00
4
Consolidated Net Income
16,042.00
15,194.00
18,973.00
13,151.00
7,403.00
6,545
Net Income
16,042.00
15,194.00
18,973.00
13,151.00
7,403.00
6,545
Net Income After Extraordinaries
16,042.00
15,194.00
18,973.00
13,151.00
7,403.00
6,545
Net Income Available to Common
16,042.00
15,194.00
18,973.00
13,151.00
7,403.00
6,545
EPS (Basic)
10.50
7.65
6.82
1.40
0.48
0.46
Basic Shares Outstanding
1,527.30
1,985.00
2,784.00
9,408.00
15,324.00
16,921
EPS (Diluted)
10.50
7.65
6.82
1.40
0.48
0.46
Diluted Shares Outstanding
1,527.30
1,985.00
2,784.00
9,408.00
15,324.00
17,058
EBITDA
15,172.00
16,646.00
20,850.00
11,030.00
7,216.00
7,605

About NovaBay Pharmaceuticals

View Profile
Address
2000 Powell Street
Emeryville California 94608
United States
Employees -
Website http://novabay.com
Updated 07/08/2019
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in commercializing and developing products for eye care. Its products include Avenova, NeutroPhase, and CelleRx. The comapny was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.